PubRank

D H Vesole

Author PubWeight™ 48.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J Virol 1990 4.01
2 Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010 3.31
3 Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood 1997 2.13
4 Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995 2.00
5 Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia 2012 1.74
6 Graft-versus-myeloma effect: proof of principle. Blood 1996 1.58
7 Identification and expression of a human cytomegalovirus early glycoprotein. J Virol 1989 1.50
8 Preceding standard therapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 1996 1.46
9 IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplant 2003 1.22
10 T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation. Blood 1999 1.08
11 Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma. J Clin Oncol 1998 1.05
12 Successful treatment of systemic and central nervous system lymphomatoid granulomatosis with rituximab. Leuk Lymphoma 2004 1.04
13 Cure of multiple myeloma -- more hype, less reality. Bone Marrow Transplant 2006 1.03
14 Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research. Leukemia 2011 1.02
15 Inhibitory effects of extracellular products from oral bacteria on human fibroblasts and stimulated lymphocytes. Infect Immun 1978 1.00
16 Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study. Biol Blood Marrow Transplant 2004 0.98
17 Multiple myeloma: an old disease with new hope for the future. CA Cancer J Clin 2001 0.97
18 Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 1995 0.96
19 Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant 2001 0.96
20 Autologous stem cell transplantation in multiple myeloma patients <60 vs >/=60 years of age. Bone Marrow Transplant 2003 0.95
21 Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood 2001 0.95
22 Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study. Clin Cancer Res 1996 0.94
23 Primary therapy with single agent bortezomib as induction, maintenance and re-induction in patients with high-risk myeloma: results of the ECOG E2A02 trial. Leukemia 2010 0.94
24 Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992 0.93
25 Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma. Bone Marrow Transplant 1997 0.91
26 Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. Bone Marrow Transplant 1995 0.89
27 Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone. Br J Haematol 2001 0.89
28 A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry. Mod Pathol 2001 0.86
29 A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an Eastern Cooperative Oncology Group Study. Bone Marrow Transplant 2004 0.86
30 Rejection of stable cultured allografts by active or passive (adoptive) immunization. Proc Natl Acad Sci U S A 1982 0.86
31 Stimulators and inhibitors of lymphocyte DNA synthesis in supernatants from human lymphoid cell lines. J Immunol 1979 0.85
32 Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone. Bone Marrow Transplant 2000 0.83
33 Activation of human lymphocytes by supernatants from human thymic epithelium. Clin Exp Immunol 1979 0.83
34 Activity of single-agent melphalan 220-300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma. Bone Marrow Transplant 2004 0.82
35 Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). Bone Marrow Transplant 2003 0.81
36 Active and suppressor T cells: diminution in a patient with dyskeratosis congenita and in first-degree relatives. Gerontology 1979 0.80
37 Transplants from the same donor. Ann Intern Med 1992 0.79
38 Relapsed multiple myeloma. Curr Treat Options Oncol 2001 0.79
39 Cunninghamella infection post bone marrow transplant: case report and review of the literature. Bone Marrow Transplant 2000 0.78
40 Outcome of unrelated transplants in patients with multiple myeloma. Bone Marrow Transplant 2005 0.77
41 Hematopoietic stem cell transplants for multiple myeloma. Leuk Lymphoma 1996 0.77
42 The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines. Immunology 1980 0.75
43 Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2000 0.75
44 Toxoplasma pneumonia: cytologic diagnosis by bronchoalveolar lavage. Diagn Cytopathol 1994 0.75
45 Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1996 0.75
46 Hemopoietic stem cell transplants for multiple myeloma. Oncology (Williston Park) 1994 0.75
47 An inhibitor of DNA synthesis produced by established lymphoid cell lines. Clin Immunol Immunopathol 1979 0.75
48 Peripheral stem cell mobilization and engraftment in patients over age 60. Bone Marrow Transplant 1997 0.75
49 Salvage therapy for multiple myeloma: the University of Arkansas experience. Mayo Clin Proc 1994 0.75
50 The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells. Bone Marrow Transplant 2005 0.75
51 Therapy for lymphoma in the elderly. J Clin Oncol 1989 0.75
52 Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose. Bone Marrow Transplant 2001 0.75
53 Adoptive immunotherapy for leukemia: donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. HGTRI 0103. Hum Gene Ther 1998 0.75
54 Plasma exchange after hematopoietic stem cell transplantation in multiple myeloma to reduce renal insufficiency. Bone Marrow Transplant 2008 0.75
55 Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report. Semin Oncol 2004 0.75
56 Acute tumour lysis syndrome: a case in AL amyloidosis. Br J Haematol 1999 0.75